StockData
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc. (KLRA) stock

KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$11.79−0.41 (-3.36%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Kailera Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kailera Therapeutics's market cap was $1.86B on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.86B–

More Kailera Therapeutics figures

See a number that looks wrong?